Please use this identifier to cite or link to this item:
Title: Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.
Authors: Koenecke, C
Heim, D
van Biezen, A
Heuser, M
Aljurf, M
Kyrcz-Krzemien, S
Volin, L
de Souza, C A
Gedde-Dahl, T
Sengeloev, H
Schanz, U
Komarnicki, M
Arroyo, C H
Tholouli, E
Gluckman, E
Esquirol, A
Yakoub-Agha, I
Gürman, G
Olavarria, E
Kröger, N
metadata.dc.subject.mesh: Adolescent
Decision Making
Hematopoietic Stem Cell Transplantation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Middle Aged
Molecular Targeted Therapy
Risk Assessment
Transplantation, Homologous
Treatment Outcome
Young Adult
Issue Date: 25-Apr-2016
metadata.dc.identifier.doi: 10.1038/bmt.2016.97
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.